BioSpace News Archive

Pharm Country

Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus

Cara Therapeutics, Inc. (Nasdaq: CARA), today announced data from a sub-study of the KARE Phase 2 clinical trial demonstrated Oral KORSUVA™ (difelikefalin) improved itch and inflammatory biomarkers in atopic dermatitis (AD) patients with moderate-to-severe pruritus.

March 28, 2022
·
3 min read
Pharm Country

Immunovant to Host Virtual R&D Day on March 30, 2022

Immunovant, Inc. today announced that it will host a virtual R&D event on Wednesday, March 30, 2022, from 9:00 AM ET to 11:00 AM ET.

March 28, 2022
·
5 min read
Business

Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Revenue Guidance

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2021.

March 28, 2022
·
16 min read
Policy

Amarin Receives Reimbursement for VAZKEPA® in Sweden

Amarin Corporation plc announces that the Company received its first national reimbursement in a European country for VAZKEPA® in Sweden and provides an update on the status of its international expansion strategy, including several regulatory filing and reimbursement updates for VASCEPA®/VAZKEPA globally.

March 28, 2022
·
11 min read